Recruiting Ankylosing Spondylitis Studies in Norfolk
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
Researchers are looking for new ways to treat triple-negative breast cancer (TNBC) and hormone receptor (HR) low positive/human epidermal growth factor receptor-2 (HER2) negative breast cancer. The ma...
Precise Infliximab Exposure and Pharmacodynamic Control
Approximately 3 million people in the United States are living with inflammatory bowel disease, which includes Crohn's Disease (CD). There are limited treatment options approved for use in children an...
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
This clinical trial is evaluating tucatinib in combination with Doxil in participants with human epidermal growth factor 2 positive (HER2+) locally advanced or metastatic breast cancer. The main goals...
PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis
The primary objective of this study is to assess the pharmacokinetics and pharmacodynamics of gefurulimab in pediatric participants with AChR+ gMG for the duration of the study....
About Ankylosing Spondylitis Clinical Trials in Norfolk
Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.
There are currently 4 ankylosing spondylitis clinical trials recruiting participants in Norfolk, VIRGINIA. These studies are seeking a combined 600 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Children's Hospital Medical Center, Cincinnati, SCRI Development Innovations, LLC and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Ankylosing Spondylitis Clinical Trials in Norfolk — FAQ
Are there ankylosing spondylitis clinical trials in Norfolk?
Yes, there are 4 ankylosing spondylitis clinical trials currently recruiting in Norfolk, VIRGINIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Norfolk?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Norfolk research site will contact you about next steps.
Are clinical trials in Norfolk free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Norfolk studies also compensate for your time and travel.
What ankylosing spondylitis treatments are being tested?
The 4 active trials in Norfolk are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.
Data updated March 2, 2026 from ClinicalTrials.gov